In both FGF9/cordycepin and Control/cordycepin groups, cordycepin treatment resulted in significantly smaller tumor volume compared to FGF9/PBS and Control/PBS groups, respectively (Figure 7A). The gene discussed is FGF9; the disease is neoplasm.